drugset / Trial / NCT00757809
Study Evaluating The Tolerability Of Multiple Doses Of HKI-272
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to investigate the occurence of diarrhea after either once daily or twice daily dosing for 14 days.
Timeline
- Start
- 2008-10
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neratinib | Small molecule | 120 mg | — |
| Subject | Neratinib | Small molecule | 240 mg | — |
Indications
No indication recorded.